nach oben

Cancer Causes & Control

Erschienen in:

01.12.2009 | Original paper

Lifetime tobacco smoke exposure and breast cancer incidence

verfasst von: Thomas P. Ahern, Timothy L. Lash, Kathleen M. Egan, John A. Baron

Erschienen in: Cancer Causes & Control | Ausgabe 10/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We analyzed data from a case–control study to assess the association between lifetime tobacco smoke exposure and breast cancer incidence.

Methods

Incident breast cancer cases were identified in the Massachusetts Cancer Registry and population controls were sampled from state Medicare lists and driver’s license rosters. Demographic, lifestyle, medical history, reproductive history, and passive and active smoking exposure variables were assessed by telephone interview. We defined passive and active tobacco smoke exposure categories reflective of lifetime exposure patterns, and compared breast cancer risk among these groups while adjusting for age, body mass index, menopausal status, parity, alcohol consumption, and family history of breast cancer. We also adjusted passive smoking associations for active smoking status and vice versa.

Results

We observed no association between ever being passively exposed to tobacco smoke and risk of incident breast cancer (adjusted OR: 1.2; 95% CI: 0.8, 1.8) nor between active smoking and breast cancer (adjusted OR for >23 pack-years compared to nonsmokers: 0.9; 95% CI: 0.7, 1.3). Null effects persisted in finer categorizations of active and passive exposure.

Conclusions

We observed no causal associations between active or passive tobacco smoke exposures and incident breast cancer, consistent with results from most prospective cohort studies.

Johnson KC (2005) Accumulating evidence on passive and active smoking and breast cancer risk. Int J Cancer 117(4):619–628CrossRefPubMed

Morabia A, Bernstein M, Heritier S, Khatchatrian N (1996) Relation of breast cancer with passive and active exposure to tobacco smoke. Am J Epidemiol 143(9):918–928PubMed

Baron JA, Newcomb PA, Longnecker MP, Mittendorf R, Storer BE, Clapp RW et al (1996) Cigarette smoking and breast cancer. Cancer Epidemiol Biomarkers Prev 5(5):399–403PubMed

Lash T, Aschengrau A (2002) A null association between active or passive cigarette smoking and breast cancer. Breast Cancer Res Treat 75(2):181–184CrossRefPubMed

Lin Y, Kikuchi S, Tamakoshi K, Wakai K, Kondo T, Niwa Y et al (2008) Active smoking, passive smoking, and breast cancer risk: findings from the Japan collaborative cohort study for evaluation of cancer risk. J Epidemiol 18(2):77–83CrossRefPubMed

Magnusson C, Wedren S, Rosenberg LU (2007) Cigarette smoking and breast cancer risk: a population-based study in Sweden. Br J Cancer 97(9):1287–1290CrossRefPubMed

Prescott J, Ma H, Bernstein L, Ursin G (2007) Cigarette smoking is not associated with breast cancer risk in young women. Cancer Epidemiol Biomarkers Prev 16(3):620–622CrossRefPubMed

Roddam AW, Pirie K, Pike MC, Chilvers C, Crossley B, Hermon C et al (2007) Active and passive smoking and the risk of breast cancer in women aged 36–45 years: a population based case–control study in the UK. Br J Cancer 97(3):434–439CrossRefPubMed

Smith S, Deacon J, Chilvers C (1994) Alcohol, smoking, passive smoking and caffeine in relation to breast cancer risk. Br J Cancer 70(1):112–119PubMed

10.

Egan KM, Stampfer MJ, Hunter D, Hankinson S, Rosner BA, Holmes M et al (2002) Active and passive smoking in breast cancer: prospective results from the nurses’ health study. Epidemiology 13(2):138–145CrossRefPubMed

11.

Johnson KC, Hu J, Mao Y, The Canadian Cancer Registries Epidemiology Research Group (2000) Passive and active smoking and breast cancer risk in Canada, 1994–97. Cancer Causes Control 11(3):211–221CrossRefPubMed

12.

Kropp S, Chang-Claude J (2002) Active and passive smoking and risk of breast cancer by age 50 years among German. Am J Epidemiol 156(7):616–626CrossRefPubMed

13.

Lash T, Aschengrau A (1999) Active and passive cigarette smoking and the occurrence of breast cancer. Am J Epidemiol 149(1):5–12PubMed

14.

Lissowska J, Brinton LA, Zatonski W, Blair A, Bardin-Mikolajczak A, Peplonska B et al (2006) Tobacco smoking, NAT2 acetylation genotype and breast cancer risk. Int J Cancer 119(8):1961–1969CrossRefPubMed

15.

Morabia A (2002) Smoking (active and passive) and breast cancer: epidemiologic evidence up to June. Environ Mol Mutagen 39(2–3):89–95CrossRefPubMed

16.

Morabia A, Bernstein, Bouchardy I, Kurtz J, Morris MA (2000) Breast cancer and active and passive smoking: the role of the N-acetyltransferase 2 genotype. Am J Epidemiol 152(3):226–232CrossRefPubMed

17.

Reynolds P, Hurley S, Goldberg DE, Anton-Culver H, Bernstein L, Deapen D et al (2004) Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. J Natl Cancer Inst 96(1):29–37PubMedCrossRef

18.

Slattery ML, Curtin K, Giuliano AR, Sweeney C, Baumgartner R, Edwards S et al (2008) Active and passive smoking, IL6, ESR1, and breast cancer risk. Breast Cancer Res Treat 109(1):101–111CrossRefPubMed

19.

Wartenberg D, Calle EE, Thun MJ, Heath CW Jr, Lally C, Woodruff T (2000) Passive smoking exposure and female breast cancer mortality. J Natl Cancer Inst 92(20):1666–1673CrossRefPubMed

20.

Zhao Y, Shi Z, Liu L (1999) Matched case–control study for detecting risk factors of breast cancer in women living in Chengdu. Zhonghua Liu Xing Bing Xue Za Zhi 20(2):91–94PubMed

21.

Newcomb PA, Storer BE, Longnecker MP, Mittendorf R, Greenberg ER, Clapp RW et al (1994) Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med 330(2):81–87CrossRefPubMed

22.

Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, (2009)

23.

Cutrufelli R, Matthews RH, United States. Dept. of Agriculture. Nutrition Monitoring Division (1986) Composition of foods: beverages: raw, processed, prepared. Rev. May 1986 ed.. U.S. Dept. of Agriculture, Washington [Supt. of Docs., U.S. G.P.O., distributor]

24.

Lisabeth LD, Beiser AS, Brown DL, Murabito JM, Kelly-Hayes M, Wolf PA (2009) Age at natural menopause and risk of ischemic stroke: the Framingham heart study. Stroke 40(4):1044–1049CrossRefPubMed

25.

Greenland S, Rothman KJ, Lash TL (2008) Modern epidemiology, 3rd edn. Lippincott, Williams & Wilkins, Philadelphia

26.

Fox MP, Lash TL, Greenland S (2005) A method to automate probabilistic sensitivity analyses of misclassified binary variables. Int J Epidemiol 34(6):1370–1376CrossRefPubMed

27.

Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CW Jr et al (2002) Alcohol, tobacco and breast cancer—collaborative reanalysis of individual data from 53 epidemiological studies, including 58, 515 women with breast cancer and 95, 067 women without the disease. Br J Cancer 87(11):1234–1245CrossRefPubMed

28.

Pirie K, Beral V, Peto R, Roddam A, Reeves G, Green J (2008) Passive smoking and breast cancer in never smokers: prospective study and meta-analysis. Int J Epidemiol 37(5):1069–1079CrossRefPubMed

Titel: Lifetime tobacco smoke exposure and breast cancer incidence
verfasst von: Thomas P. Ahern
Timothy L. Lash
Kathleen M. Egan
John A. Baron
Publikationsdatum: 01.12.2009
Verlag: Springer Netherlands
Erschienen in: Cancer Causes & Control / Ausgabe 10/2009
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-009-9376-1

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Lifetime tobacco smoke exposure and breast cancer incidence

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

Update Onkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2009

Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened

Age at incident treatment of hypertension and risk of cancer: a population study

Cigarette smoking and risk of prostate cancer among Singapore Chinese

Involvement of the IGF system in fetal growth and childhood cancer: an overview of potential mechanisms

Hypothesis: neoplasms in myotonic dystrophy

Influence of tumor stage, symptoms, and time of blood draw on serum concentrations of organochlorine compounds in exocrine pancreatic cancer

Neu im Fachgebiet Onkologie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

Update Onkologie